Cargando…

Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study

BACKGROUND: The link between type 1 diabetes and thyroid autoimmunity is well described. The same cannot be said for type 2 diabetes where results have been mixed so far. We investigated the prevalence and determinants of thyroid autoimmunity among Ghanaian type 2 diabetes patients. METHODS: This wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarfo-Kantanka, Osei, Sarfo, Fred Stephen, Ansah, Eunice Oparebea, Yorke, Ernest, Akpalu, Josephine, Nkum, Bernard C., Eghan, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286684/
https://www.ncbi.nlm.nih.gov/pubmed/28143459
http://dx.doi.org/10.1186/s12902-016-0152-4
_version_ 1782504043026841600
author Sarfo-Kantanka, Osei
Sarfo, Fred Stephen
Ansah, Eunice Oparebea
Yorke, Ernest
Akpalu, Josephine
Nkum, Bernard C.
Eghan, Benjamin
author_facet Sarfo-Kantanka, Osei
Sarfo, Fred Stephen
Ansah, Eunice Oparebea
Yorke, Ernest
Akpalu, Josephine
Nkum, Bernard C.
Eghan, Benjamin
author_sort Sarfo-Kantanka, Osei
collection PubMed
description BACKGROUND: The link between type 1 diabetes and thyroid autoimmunity is well described. The same cannot be said for type 2 diabetes where results have been mixed so far. We investigated the prevalence and determinants of thyroid autoimmunity among Ghanaian type 2 diabetes patients. METHODS: This was a case-control study involving 302 type 2 diabetes patients and 310 non - diabetic controls aged 40–80 years. Anthropometric and blood pressure measurements were obtained. Fasting samples were analyzed for glucose, thyroid function, and antibodies to thyroglobulin and thyroid peroxidase. RESULTS: The prevalence of thyroid autoimmunity was significantly higher among T2DM subjects (12.2% vs. 3.9%, p = 0.0004). Among T2DM subjects, 44 (14.7%) tested positive for TPOAb, 5 (1.7%) tested positive for TGAb and 15 (5.0%) tested positive for both autoantibodies. Females T2DM subjects showed a 3-fold increased risk of thyroid autoimmunity compared to males (OR:3.16, p =0.004), T2DM subjects with hyperthyroidism had a 41% increased risk of thyroid autoimmunity (OR: 1.41, p < 0.001), sub-clinical hyperthyroidism increased the risk of thyroid autoimmunity by 2 fold, (OR:2.19, p < 0.001), subclinical hypothyroidism increased the risk of autoimmunity by 4-fold, (OR:3.57 95% p < 0.0001), and hypothyroidism was associated with a 61% increased risk of thyroid autoimmunity (OR: 1.61,1.35–2.23). Dyslipidaemia was associated with a 44% increased risk of thyroid autoimmunity (OR: 1.44, p = 0.01) and a percentage increase in HbA1c was associated with 46% increased risk of thyroid autoimmunity (OR:1.46, p < 0.0001). CONCLUSION: We observed a high prevalence of thyroid autoimmunity in Ghanaian T2DM subjects compared to the general population. Thyroid autoimmunity in T2DM subjects was significantly associated with female gender, thyroid dysfunction, dyslipidaemia and poor glycemic control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12902-016-0152-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5286684
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52866842017-02-03 Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study Sarfo-Kantanka, Osei Sarfo, Fred Stephen Ansah, Eunice Oparebea Yorke, Ernest Akpalu, Josephine Nkum, Bernard C. Eghan, Benjamin BMC Endocr Disord Research Article BACKGROUND: The link between type 1 diabetes and thyroid autoimmunity is well described. The same cannot be said for type 2 diabetes where results have been mixed so far. We investigated the prevalence and determinants of thyroid autoimmunity among Ghanaian type 2 diabetes patients. METHODS: This was a case-control study involving 302 type 2 diabetes patients and 310 non - diabetic controls aged 40–80 years. Anthropometric and blood pressure measurements were obtained. Fasting samples were analyzed for glucose, thyroid function, and antibodies to thyroglobulin and thyroid peroxidase. RESULTS: The prevalence of thyroid autoimmunity was significantly higher among T2DM subjects (12.2% vs. 3.9%, p = 0.0004). Among T2DM subjects, 44 (14.7%) tested positive for TPOAb, 5 (1.7%) tested positive for TGAb and 15 (5.0%) tested positive for both autoantibodies. Females T2DM subjects showed a 3-fold increased risk of thyroid autoimmunity compared to males (OR:3.16, p =0.004), T2DM subjects with hyperthyroidism had a 41% increased risk of thyroid autoimmunity (OR: 1.41, p < 0.001), sub-clinical hyperthyroidism increased the risk of thyroid autoimmunity by 2 fold, (OR:2.19, p < 0.001), subclinical hypothyroidism increased the risk of autoimmunity by 4-fold, (OR:3.57 95% p < 0.0001), and hypothyroidism was associated with a 61% increased risk of thyroid autoimmunity (OR: 1.61,1.35–2.23). Dyslipidaemia was associated with a 44% increased risk of thyroid autoimmunity (OR: 1.44, p = 0.01) and a percentage increase in HbA1c was associated with 46% increased risk of thyroid autoimmunity (OR:1.46, p < 0.0001). CONCLUSION: We observed a high prevalence of thyroid autoimmunity in Ghanaian T2DM subjects compared to the general population. Thyroid autoimmunity in T2DM subjects was significantly associated with female gender, thyroid dysfunction, dyslipidaemia and poor glycemic control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12902-016-0152-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-17 /pmc/articles/PMC5286684/ /pubmed/28143459 http://dx.doi.org/10.1186/s12902-016-0152-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sarfo-Kantanka, Osei
Sarfo, Fred Stephen
Ansah, Eunice Oparebea
Yorke, Ernest
Akpalu, Josephine
Nkum, Bernard C.
Eghan, Benjamin
Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
title Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
title_full Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
title_fullStr Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
title_full_unstemmed Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
title_short Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
title_sort frequency and determinants of thyroid autoimmunity in ghanaian type 2 diabetes patients: a case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286684/
https://www.ncbi.nlm.nih.gov/pubmed/28143459
http://dx.doi.org/10.1186/s12902-016-0152-4
work_keys_str_mv AT sarfokantankaosei frequencyanddeterminantsofthyroidautoimmunityinghanaiantype2diabetespatientsacasecontrolstudy
AT sarfofredstephen frequencyanddeterminantsofthyroidautoimmunityinghanaiantype2diabetespatientsacasecontrolstudy
AT ansaheuniceoparebea frequencyanddeterminantsofthyroidautoimmunityinghanaiantype2diabetespatientsacasecontrolstudy
AT yorkeernest frequencyanddeterminantsofthyroidautoimmunityinghanaiantype2diabetespatientsacasecontrolstudy
AT akpalujosephine frequencyanddeterminantsofthyroidautoimmunityinghanaiantype2diabetespatientsacasecontrolstudy
AT nkumbernardc frequencyanddeterminantsofthyroidautoimmunityinghanaiantype2diabetespatientsacasecontrolstudy
AT eghanbenjamin frequencyanddeterminantsofthyroidautoimmunityinghanaiantype2diabetespatientsacasecontrolstudy